Proto Axiom
}}
| Privately held company | |
| ISIN | 🆔 |
| Industry | Venture Capital |
| Genre | Biotechnology |
| Founded 📆 | 2021 |
| Founder 👔 | Anthony Liveris, Catalio Capital, Tristan Edwards |
| Headquarters 🏙️ | , , |
Area served 🗺️ | |
| 💎 AUM | $15 million |
| Members | |
Number of employees | |
| 🌐 Website | [Lua error in Module:WikidataIB at line 665: attempt to index field 'wikibase' (a nil value). ] |
| 📇 Address | |
| 📞 telephone | |
Proto Axiom is an Australian venture capital firm.[1] The firm is headquartered in Sydney, New South Wales, and specialises in seed stage, early stage, and growth stage investments in private companies across the biotechnology sector. As of 2022,[update] Proto Axiom's total assets under management were approximately US$15 million.[2]
History
Proto Axiom was founded in 2021 by Catalio Capital Management, Anthony Liveris, and Tristan Edwards.[3]
Proto Axiom’s business model, says Liveris, is to “take majority stakes in promising IP out of Australian universities, mature it internally for two to three years by working with partner organisations, and then spin it out”.[1]
The firm has announced $15 million in funding.[4]
Investments
Proto Axiom has announced an investment in Endo Axiom.[5][6][7]
References
- ↑ 1.0 1.1 KORPORAAL, GLENDA (30 September 2022). "Backing biotechs with US-style entrepreneurialism". The Australian.
- ↑ "Asia Digest: Saluda Medical raises $150m; Proto Axiom closes Series A round". DealStreetAsia. Retrieved 2023-04-27.
- ↑ Staff, TechNode Global (2023-04-17). "Australian biomedical technology incubator Proto Axiom raises $15M in Series A funding". TechNode Global. Retrieved 2023-04-27.
- ↑ "Tech in Asia - Connecting Asia's startup ecosystem". www.techinasia.com. Retrieved 2023-04-27.
- ↑ "TTRA News: Awardee Spin-off Developing Oral Insulin Technology Gets Commercial Backing : MTPConnect". www.mtpconnect.org.au. Retrieved 2023-04-27.
- ↑ "Spin-off developing oral insulin receives commercial backing in Australia". www.biospectrumasia.com. Retrieved 2023-04-27.
- ↑ "Proto Axiom invests in University of Sydney spin-out, EndoAxiom". biotechdispatch.com.au. Retrieved 2023-04-27.
External links
| Basic investment types |  | ||||||
|---|---|---|---|---|---|---|---|
| History | |||||||
| Terms and concepts |
| ||||||
| Investors | |||||||
| Related financial terms | |||||||
References
This article "Proto Axiom" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Proto Axiom. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
